Differing definitions of iron deficiency lead to divergent estimates of prevalence, study finds

FHS
June 12, 2024
8:59 am

How different ways of defining iron deficiency (ID) impact the prevalence estimates of this common disorder among women.

Cognition Therapeutics’ stock sinks on Phase 2 Alzheimer’s data

New Alzheimer’s data from Cognition Therapeutics appeared to show an early drug effect, but one that lessened over time. Cognition presented Phase 2 results from

July 30, 2024

The importance of trust in AI as a medical device

Alison Dennis is a London-based partner with law firm Taylor Wessing, where she co-heads the international life sciences team specializing in regulatory and transactional representation.

June 15, 2023

PharmAla and Red Light Holland to Collaborate on Medical Psilocybin Development | Psychedelic Invest

VANCOUVER, British Columbia, Feb. 09, 2024 (GLOBE NEWSWIRE) — PharmAla Biotech Holdings Inc. (“PharmAla”) (CSE: MDMA) (OTC:MDXXF), a biotechnology company focused on the research, development,

February 9, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.